Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia

Clinical trial NCT00606593 · COMPLETED

Trial details

NCT number: NCT00606593
Sponsor: Midnight Pharma, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Primary Insomnia

Start date: 2007-12-01
Primary completion: 2008-04-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.